Bovi-Tect PI

This modified live vaccine reduces the incidence of morbidity and mortality caused by Mannheimia haemolytica and BHV-1 (IBR).

FOR ANIMAL USE ONLY

BOVI-TECT PI

Reg. No. G3001 (Act 36/1947)

Namibia Reg. No. V02/24.4/786 [NS0]

INDICATIONS

The combination vaccine reduces the incidence of morbidity and mortality caused by undifferentiated bovine respiratory diseases (pasteurellosis) associated with M. (Pasteurella) haemolytica and BHV 1 (infectious bovine rhinotracheitis – IBR).

This vaccine is also recommended for inclusion in a vaccination programme for feedlot cattle at processing.

COMPOSITION

Mannheimia (Pasteurella) haemolytica biotype A serotype 1/17 cell-free supernatant leukotoxin vaccine for cattle, to be used in conjunction with modified live bovine herpes virus 1 (BHV 1), supplied in a smaller vial labeled Bovi-Tect PI IBR component.

For optimal use, consult your veterinarian.

STORAGE

  • Store in a refrigerator between 2 ˚C and 8 ˚C.
  • Do not freeze.
  • Protect from direct sunlight.

WARNINGS

  • NOT TO BE USED IN PREGNANT ANIMALS.
  • For use in cattle only.
  • For use in cattle from 3 months of age.
  • Dispose of any unused vaccine, as well as all empty vaccine containers and vaccination equipment, according to local waste disposal regulations.
  • Do not attempt to store partially used vaccine for later use.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

  • Use sterile needles and syringes and aseptic procedures.
  • Where chemical sterilisation of needles and syringes is practiced, rinse needles and syringes in boiled, cooled water before reuse, to ensure that the modified live virus component is not destroyed by the disinfectant.
  • Ensure that the vaccine is kept cool. Protect vaccine from direct sunlight while administering.
  • A booster Bovi-Tect PI vaccine is recommended after 10 to 21 days for an optimal immune response.

For the 100 mℓ pack size – draw up 2 mℓ to 3 mℓ of the M. (Pasteurella) haemolytica leukotoxin component from the 100 mℓ vial and inject into the smaller 7 mℓ glass vial containing the modified, live BHV 1 virus. Aspirate contents and transfer back into the large 100 mℓ vial. Mix gently to distribute the virus evenly in the liquid.

For the 20 mℓ pack size – draw up 2 mℓ to 3 mℓ of the M. (Pasteurella) haemolytica leukotoxin component from the 20 mℓ vial and inject into the 7 mℓ glass vial containing the modified, live BHV 1 virus. Aspirate contents and transfer back into the 20 mℓ vial. Mix gently to distribute the virus evenly in the liquid.

For the 10 mℓ pack size – draw up 2 mℓ to 3 mℓ of the M. (Pasteurella) haemolytica leukotoxin component from the 10 mℓ vial and inject into the 7 mℓ glass vial containing the modified, live BHV 1 virus. Aspirate contents and transfer back into the 10 mℓ vial. Mix gently to distribute the virus evenly in the liquid.

* Note: the contents of the 7 mℓ glass vials for the 10 mℓ, 20 mℓ  and 100 mℓ pack sizes are not interchangeable.

DOSAGE

1 mℓ of the combination vaccine per animal, administered subcutaneously.

PRESENTATION

A 10 mℓ (10 doses), 20 mℓ (20 doses) or 100 mℓ (100 doses) HDPE (plastic) vial containing the
M. haemolytica leukotoxin component and a 7 mℓ glass vial containing freeze-dried BHV 1 virus.

Not all pack sizes may necessarily be marketed.

REGISTRATION HOLDER                                        

Intervet South Africa (Pty) Ltd.                                   

20 Spartan Road, Spartan                                          

1619, RSA                                                                  

Tel: +27 (0)11 923 9300

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT 8 August 2019